1. Home
  2. Live Updates
  3. Division of hematology oncology

Live Breaking News & Updates on Division of hematology oncology

Stay informed with the latest breaking news from Division of hematology oncology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Division of hematology oncology and stay connected to the pulse of your community

Dr Jurcic on the Use of JAK Inhibitors in Myelofibrosis Management

Joseph G. Jurcic, MD, discusses the use of JAK inhibitors in the management of myelofibrosis.

Josephg-jurcic , Columbia-university-herbert-irving-comprehensive-cancer-center , Columbia-university-medical-center , Division-of-hematology-oncology , Hematologic-malignancies-section ,

Dr Kirkwood on the Evolving Treatment of Resected Melanoma

John M. Kirkwood, MD, discusses the significance of the FDA approval of adjuvant nivolumab for patients with resected stage IIB or IIC melanoma.

Johnm-kirkwood , University-of-pittsburgh , Division-of-hematology-oncology , Oncologic-drug-advisory-committee , Service-professor-of-medicine , Skin-cancer-program , Distinguished-service-professor , Thomas-usher-professor , Translational-science , Drug-advisory-committee , D

Dr Dreicer on the Different Approaches to mCRPC Management

Robert Dreicer, MD, discusses different approaches in prostate cancer management according to the type of oncologist.

Robert-dreicer , Division-of-hematology-oncology , University-of-virginia-cancer-center , Virginia-cancer-center , Mcrpc , Prostate-cancer-management- , D ,

Dr Ball on the Use of Luspatercept in MDS With Anemia

Somedeb Ball, MBBS, discusses the benefits of luspatercept for patients with anemia due to a myelodysplastic syndrome.

Department-of-medicine , Division-of-hematology-oncology , Vanderbilt-university-medical-center , Somedeb-ball , Hematology-oncology , Bbs , Luspatercept , Patients-with-anemia-due-toa-myelodysplastic-syndrome ,

Dr Sahin on the Design of the Northstar Response Assay in Advanced GI Cancer

Ilyas Sahin, MD, discusses the Northstar Response assay and the future of precision oncology in patients with advanced gastrointestinal cancer.

Ilyas-sahin , University-of-florida-college-medicine , Department-of-medicine , Division-of-hematology-oncology , Florida-college , Northstar-response , D , Northstar-response-assay , The-future-of-precision-oncology , Patients-with-advanced-gastrointestinal-cancer ,

TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline

$158M Series B-2 Financing led by Deep Track Capital, with new participation from leading global biotechnology investors including RA Capital Management,...

Dave-licata , Vince-ruiz , Ribociclib-kisqali , Mark-alles , Palbociclib-ibrance , Dennis-slamon , Perceptive-xontogeny-venture-fund , Slamon-research-laboratory , Bristol-myers-squibb , Division-of-hematology-oncology , Roth-zabel , Crandon-law

TORL BioTherapeutics Raises $158M in Series B-2 Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Los-angeles , Dennis-slamon , Mark-alles , Perceptive-xontogeny-venture-fund , Bristol-myers-squibb , Division-of-hematology-oncology , Slamon-research-lab , David-geffen-school , Deep-track-capital , Perceptive-advisors , Avidity-partners , Goldman-sachs-alternatives

Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors

BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precisio...

California , United-states , University-of-southern-california , San-diego , Boulder , Colorado , Sam-kintz , Lori-kunkel , Eli-lilly , Los-angeles , Division-of-hematology-oncology , Enliven-therapeutics-inc

Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors

Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University-of-southern-california , California , United-states , Colorado , Boulder , San-diego , Sam-kintz , Los-angeles , Eli-lilly , Lori-kunkel , Enliven-therapeutics-inc , Company-nasdaq

National Cancer Institute Brings Together 13 Cancer Equity Leaders

Group will help Center to Reduce Cancer Health Disparities determine NCI’s diversity training, biomedical workforce development, and community outreach and engagement initiatives...

Puerto-rico , Charlesl-spurr , Ruben-mesa , Marcia-cruz-correa , Priscilla-ulene , Selwyn-vickers , Morgan-helen-chu , Taofeek-owonikoko , Cheryl-willman , Kunle-odunsi , Benjaminf-byrd-jr , Robert-winn